Fairmount is a Philadelphia-based investment firm dedicated to investing in promising new therapies pursued by biotechnology and life science companies.

Fairmount Funds

Fairmount Funds Management LLC | 948 followers on LinkedIn. Dedicated to investing in promising new therapies pursued by biotechnology
and life science companies | Fairmount is a registered investment adviser with $2.5B+ AUM dedicated to investing in promising new biotechnology companies with a focus on differentiated therapeutics, robust research organizations, and experienced management teams.

Interim CEO

Jonathan Violin

Director of Research at Fairmount Funds Management LLC

Chris Cain

Operating Partner @ Fairmount Funds | PharmD

Michelle Pernice

M.A., Organizational Psychology 🔸 Experienced People & Culture Leader

Laurie Politz

Fairmount Funds Management LLC

CrUX Dataset

CrUX Top 50m

Director of Research

Executive Assistant

Ariel Mcardle

Chief Compliance Officer

Erin O'Connor

Principal

Jack Krieger

Head of Finance/Operations

Matt Ehrhart

Senior Vice President, Regulatory Affairs

Managing Member

Peter Harwin

Samantha Clemens

Tomas Kiselak

Co-Founder and Managing Member

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden. 

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.

Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Investors Active in Philadelphia, Pennsylvania

Hedge Funds with Investments in East Coast

Post IPO Investors with Investments in Silicon Valley

United States Investors (Top 10K)

Fairmount Funds Management is a Philadelphia-based investment firm.

Fairmount Healthcare Co-Invest III

Fairmount Healthcare Fund

Philadelphia

Pennsylvania

United States

North America

Fairmount Funds Management

The 10 Biggest Rounds Of September: Safe Superintelligence’s $1B Raise Reigns Supreme

The Week’s 10 Biggest Funding Rounds: Another Big Week For Biotech And AI

The Week’s 10 Biggest Funding Rounds: Entertainment And Supply Chain Lead In Another Busy Week Of Funding

India

Asia

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 15, 2024 1:51 PM	e6192c14
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 15, 2024 1:51 PM	6749144c
crunchbase trigger	general	Nov 15, 2024 1:51 PM	a6712e88
crunchbase profile	general	Nov 15, 2024 11:17 PM	4009bca5
li profile	general	Nov 15, 2024 1:51 PM	7195cd88
translate crunchbase fundingrounds	general	Nov 15, 2024 11:40 PM	8fbe3e94
peers	general	Nov 15, 2024 1:51 PM	177fd7aa
news basic	general	Nov 15, 2024 1:51 PM	82e43e62
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

FAIR

COM:FAIRMOUNTFUNDS

Fairmount Funds